Immuron Finalizes Small Shareholder Buyback, Cancels 3.8 Million Shares
IMRN sits 55% above its 52-week low of $0.677.
Summary
Immuron Ltd has formally completed its small shareholder buyback program, cancelling over 3.8 million shares at AUD 0.032 each, reducing the total outstanding shares by more than 1%.
Key Events · Financing and Capital Events · IMRN
-
Share Cancellation Completed
Immuron has formally ceased 3,805,528 ordinary fully paid shares, reducing the total outstanding shares.
-
Buyback Details Finalized
The shares were cancelled as part of a buyback of unmarketable parcels, with a consideration of AUD 0.032 per share.
-
Follows Prior Announcement
This filing provides the final details and formal notification of an event previously announced as completed on June 23, 2026.
Analysis · IMRN · Life Sciences
This filing provides the final details of the small shareholder buyback program, which was previously announced as completed on June 23, 2026. The company has formally ceased 3,805,528 shares at a price of AUD 0.032 per share, totaling approximately AUD 121,777. This share cancellation reduces the total outstanding shares by over 1%, which is a positive step for existing shareholders by increasing their proportional ownership.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 29.6% of the 2856 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.04%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IMRN was trading at $1.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.7M. The 52-week trading range was $0.68 to $2.39. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.